Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod for Chemoprevention of Recurrent and High-Grade CIN
NCT00031759Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jun 1999
- Primary completion
- Jul 2004
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of imiquimod in cervical intraepithelial neoplasia (CIN), sponsored by Cancer and Leukemia Group B. Started Jun 1999; status: completed.
02
Drugs
imiquimod
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT00031759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00031759.